Impact of lung and heart immaturity when investigating medicinal products intended for neonatal use

Current version

PDF iconConcept paper

Reference numberEMEA/CHMP/PEG/114218/06
Published18/11/2015
KeywordsNeonates, medicines, drugs, developmental pharmacology, adreno-receptors, immaturity, lung, heart, surfactant
DescriptionThis document specifically discusses the impact of lung and heart immaturity when investigating medicinal products in term and preterm newborns and infants.


Related content


How useful was this page?

Add your rating